Product Information
SIMVASTATIN 40 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $0.0538 per EA under NDC 70377000414. Its NADAC has been published 421 times since Sep 12, 2018.
FDA first approved this application on Dec 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377000414
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA078034FDA Approved
12/20/2006
TE Code
AB
On Market Since
12/17/2015
Pharmacological Classes
Price Statistics
The NADAC for SIMVASTATIN 40 MG TABLET has been published 421 times since Sep 12, 2018, and over the history we have for it it has risen 60.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0538 per EA |
|---|---|
| All-time high | $0.0701 (Nov 15, 2023) |
| All-time low | $0.0334 (Sep 12, 2018) |
| 52-week high | $0.0547 |
| 52-week low | $0.0519 |
| Median price | $0.0445 |
| Average price | $0.0482 |
| Largest weekly change | +29.8% (Aug 21, 2024) |
| Weeks tracked | 421 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Simvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIMVASTATIN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 40 MG TABLET, manufactured by Biocon Pharma Inc., is $0.0538 per EA (NDC 70377000414), effective Sep 30, 2026.
How has the price of SIMVASTATIN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIMVASTATIN 40 MG TABLET has risen 60.8%. It has been tracked across 421 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for SIMVASTATIN 40 MG TABLET?
Since Sep 12, 2018, the NADAC for SIMVASTATIN 40 MG TABLET has ranged from a low of $0.0334 (Sep 12, 2018) to a high of $0.0701 (Nov 15, 2023), with a median of $0.0445 per EA.
Are there cheaper alternatives to SIMVASTATIN 40 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 40 MG TABLET, is $0.0410 per EA — about 24% below SIMVASTATIN 40 MG TABLET.
Who manufactures SIMVASTATIN 40 MG TABLET?
SIMVASTATIN 40 MG TABLET (NDC 70377000414) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.